# Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Sepsis.

> **NCT03764085** · PHASE4 · COMPLETED · sponsor: **Yuria-Pharm** · enrollment: 180 (actual)

## Conditions studied

- Sepsis
- Intoxication; Septic

## Interventions

- **DRUG:** Rheosorbilact®
- **DRUG:** Ringer lactate

## Key facts

- **NCT ID:** NCT03764085
- **Lead sponsor:** Yuria-Pharm
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-06
- **Primary completion:** 2019-12-11
- **Final completion:** 2019-12-11
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2020-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03764085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03764085, "Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Sepsis.". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03764085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*